日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Kaempferol Alleviates Carbon Tetrachloride-Induced Liver Fibrosis in Mice by Regulating Intestinal Short-Chain Fatty Acids.

山奈酚通过调节肠道短链脂肪酸减轻四氯化碳诱导的小鼠肝纤维化

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms26146666
Zhang Siqi, Tang Fei, Zhou Zhe, Li Linhui, Tang Yang, Fu Kaiwen, Tan Yang, Li Ling
其它
肠道菌群
发表日期：2025
文献求助 收藏

Correction: Case Report: Curative effect and mechanism of surufatinib combined with toripalimab in the treatment of 1 case of lung large-cell neuroendocrine carcinoma

更正：病例报告：舒鲁法替尼联合托瑞普利单抗治疗1例肺大细胞神经内分泌癌的疗效及机制

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1730518
Xiong, Shuanglong; Yang, Chengxiang; Fu, Kaiwen; Liao, Xingyun; Ding, Yao; Zhou, Kexue; Zhang, Li; Teng, Yan; Wu, Chunman; Li, Yongsheng; Liang, Houjie; Li, Yan
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Case Report: Personalized diagnosis and treatment strategies for three cases of cancer of unknown primary based on molecular testing techniques

病例报告：基于分子检测技术的3例原发灶不明癌症的个体化诊断和治疗策略

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1505271
Ding, Yao; Zhou, Kexue; Fu, Kaiwen; Liao, Xingyun; Xiong, Shuanglong; Yang, Chengxiang; Hu, Mingyang; Liang, Guanzhong; Zeng, Xianghua; Li, Yongsheng; Wang, Donglin; Li, Yan
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Case report: Curative effect and mechanism of surufatinib combined with toripalimab in the treatment of 1 case of lung large-cell neuroendocrine carcinoma

病例报告：舒鲁法替尼联合托瑞普利单抗治疗1例肺大细胞神经内分泌癌的疗效及机制

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1527719
Xiong, Shuanglong; Yang, Chengxiang; Fu, Kaiwen; Liao, Xingyun; Ding, Yao; Zhou, Kexue; Zhang, Li; Teng, Yan; Wu, Chunman; Li, Yongsheng; Liang, Houjie; Li, Yan
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏